GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renhe Pharmacy Co Ltd (SZSE:000650) » Definitions » Selling, General, & Admin. Expense

Renhe Pharmacy Co (SZSE:000650) Selling, General, & Admin. Expense : ¥239 Mil (TTM As of Sep. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Renhe Pharmacy Co Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Renhe Pharmacy Co's selling, general, & admin. expense for the three months ended in Sep. 2024 was ¥418 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Sep. 2024 was ¥239 Mil.


Renhe Pharmacy Co Selling, General, & Admin. Expense Historical Data

The historical data trend for Renhe Pharmacy Co's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renhe Pharmacy Co Selling, General, & Admin. Expense Chart

Renhe Pharmacy Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 487.76 333.71 372.51 360.98 305.63

Renhe Pharmacy Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 463.02 -343.42 261.83 -97.40 417.64

Competitive Comparison of Renhe Pharmacy Co's Selling, General, & Admin. Expense

For the Drug Manufacturers - Specialty & Generic subindustry, Renhe Pharmacy Co's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Renhe Pharmacy Co's Selling, General, & Admin. Expense Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Renhe Pharmacy Co's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Renhe Pharmacy Co's Selling, General, & Admin. Expense falls into.



Renhe Pharmacy Co Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥239 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Renhe Pharmacy Co  (SZSE:000650) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Renhe Pharmacy Co Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Renhe Pharmacy Co's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Renhe Pharmacy Co Business Description

Traded in Other Exchanges
N/A
Address
No. 998, Honggutan Road, Greenland Central Plaza, 18th Floor, Yuanchuang International, Zone B, Honggutan New District, Jiangxi Province, Nanchang, CHN, 330038
Renhe Pharmacy Co Ltd is a China-based company engaged in the production and sale of Chinese and Western medicine, bulk drugs and health-related products. The products include oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, tinctures, suppositories, ointments and other pharmaceutical products and health-related products. The company's main products are Renhe Kelik, Youkadan series, Fu Yan Jie series, Dahuoluo capsules, shiny eye drops, Qinghuo capsules, Zhengwei capsules and others.
Executives
Yang Xiao Director
Kang Zhi Hua Supervisors
Mei Qiang Directors, executives
Yang Wen Long Director

Renhe Pharmacy Co Headlines

No Headlines